Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapix Biosciences Ltd.

0.3170
0.0000
Volume:- -
Turnover:- -
Market Cap:1.81M
PE:-0.11
High:0.3170
Open:0.3170
Low:0.3170
Close:0.3170
Loading ...

Company Profile

Company Name:
Therapix Biosciences Ltd.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include THX-110, which has completed Phase II a clinical trial for the treatment of Tourette syndrome and Obstructive Sleep Apnea; THX-160, which has completed two preliminary preclinical studies for the treatment of acute and chronic pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy. The company was formerly known as NasVax Ltd. and changed its name to Therapix Biosciences Ltd. in November 2013. Therapix Biosciences Ltd. was founded in 2004 and is headquartered in Givatayim, Israel.